Schumacher Daniel sold $477K of PRLB

Arrow Electronics (ARW), Methode Electronics (MEI), Proto Labs (PRLB), and SolarEdge (SEDG) shares rose after weaker-than-expected U.S. jobs data lowered Treasury yields. The Bureau of Labor Statistics reported nonfarm payrolls increased by 29,000 in September, below expectations. Lower yields ease borrowing costs for industrial companies, but slower hiring may signal economic cooling. SolarEdge's stock is up 5.4% year-to-date but remains 57.9% below its 52-week high.

Proto Labs (PRLB) appointed Sam Ramahi as Chief Operations Officer, focusing on operational leadership and global supply chain management. The stock has seen a 12-month total shareholder return of 60.09% and a year-to-date return of 55.29%, closing at $79.74. Analysts debate whether the current price reflects its shift, with a fair value estimate of $95.50, citing strong cash generation and growth potential. However, risks include customer concentration and weakness in Europe, and the stock trad

Proto Labs (PRLB) appointed Sam Ramahi as COO to oversee global operations and supply chain. Investors watch how his experience may impact the company's shift from prototyping to scalable production. Proto Labs projects $697.6M revenue and $58.5M earnings by 2029, a 24% upside from current prices, requiring 7.6% yearly revenue growth.

Protolabs (PRLB) appointed Sam Ramahi as COO to lead global operations. Ramahi, with 25 years of experience, will oversee supply chain, quality, and continuous improvement. He previously led operations at SIG Group and Jacuzzi. The move supports Protolabs' strategy to expand from prototyping to production, aiming to improve performance and create value for shareholders.

Proto Labs (NYSE:PRLB) reported Q2 FY2026 revenue of $149.3 million, up 10.2% in constant currency, and non-GAAP EPS of $0.60. Non-GAAP gross margin rose to 46.8%. Q3 revenue guidance is $145 million to $153 million, with non-GAAP EPS of $0.56 to $0.64. Full-year 2026 revenue growth guidance was raised to 8% to 10%.

Proto Labs (PRLB) reported Q2 FY2026 revenue of $149.3 million, up 10.2% in constant currency, with non-GAAP EPS of $0.60. Non-GAAP gross margin rose to 46.8% and adjusted EBITDA was $25.1 million. Q3 revenue guidance is $145 million to $153 million, and full-year 2026 revenue growth guidance was raised to 8% to 10%. Cash and investments were $162.9 million with zero debt.